CJC-1295 w/ Ipamorelin

CJC-1295 w/ Ipamorelin is a research blend that pairs two well-studied synthetic peptides in a single vial: CJC-1295 (no DAC), a modified growth hormone-releasing hormone (GHRH) analog, and Ipamorelin, a selective growth hormone secretagogue. It is supplied as a high-purity lyophilized powder for controlled laboratory work. Research background: Both peptides appear widely in the preclinical literature on growth hormone signaling. CJC-1295 is studied at the GHRH receptor, while Ipamorelin is studied at the ghrelin receptor (GHS-R1a), so the blend lets researchers examine both pathways together. Research context: Compared with experiments using either peptide on its own, the combination supports broader studies of peptide interactions, receptor signaling, and stability in controlled in-vitro and preclinical model systems. Form: 10 mg total (5 mg CJC-1295 no DAC / 5 mg Ipamorelin) white lyophilized powder in a 3 mL vial. Requires reconstitution before use. Storage: Keep sealed vials cool, dry, and away from heat and light. After reconstitution, refrigerate at 2–8°C. Sold strictly for in-vitro research and laboratory use. Not for human or veterinary use, and not a drug, food, or cosmetic.

• Ships within the domestic U.S. only
• Estimated delivery: 3–7 business days
• For research use only. Not for human use.